Chronic hypertension classification: Difference between revisions

	Chronic Hypertension Microchapters
Home
2017 ACC/AHA Hypertension Guidelines
Patient Information
Overview
Definition
Classification
Pathophysiology
Causes
Differentiating Hypertension from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Blood Pressure Measurement
Physical Examination
Laboratory Findings
Electrocardiogram
ETT
Echocardiography
CT
MRI
Other Diagnostic Studies
Treatment
Lifestyle Modification
Medical Therapy Practice Guidelines
Case Studies
Case #1
Chronic hypertension classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Chronic hypertension classification
CDC on Chronic hypertension classification
Chronic hypertension classification in the news
Blogs on Chronic hypertension classification
Directions to Hospitals Treating Chronic hypertension classification
Risk calculators and risk factors for Chronic hypertension classification

VisualWikitext

Revision as of 14:33, 17 May 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor-In-Chief: Yazan Daaboul, Serge Korjian

Overview

In 2004, the Seventh Report of the Joint National Committee (JNC 7) classified blood pressure values into 4 categories: normal, prehypertension, stage I hypertension, and stage II hypertension.^[1] In 2007, the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) classified blood pressure into 7 categories.^[2] This classification remained unchanged in the 2013 ESH/ESC classification.^[3] The ESH/ESC classification excludes JNC 7’s pre-hypertension category, but includes 3 different grades of hypertension in contrast to JNC 7’s two-stage classification of hypertension.

Classification

2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults (JNC8) -- DO NOT EDIT

**Comparison of Current Recommendations With JNC 7 Guidelines**
Disease	Transmission	Incubation	Incidence	Deaths	Incidence	Deaths	Incidence	Deaths
Disease	Characteristics		Worldwide		U.S.		U.K.
Diphtheria	Saliva	1-4 days	30,000	3,000	1	0	0	0
Haemophilus influenzae	Airborne droplet	1-4 days	2-3,000,000	450,000 (mostly children)	1,743	7	30	0
Hepatitis B	Contact with body fluids	6 weeks - 6 months	5,700,000 (acute)	521,000	7,996	7	600	Not reported
Measles	Airborne	10-12 days	30-40,000,000	610,000	44	0	77	1
Mumps	Airborne droplets	14-21 days	477,079 (reported)	N/A	270	1	16,436	0
Pertussis	Airborne droplets	5-10 days	39,000,000	297,000	9,771	18	2	2
Polio	Fecal contamination	Hours	1,951	<1,000	0	0	0	0
Rubella	Airborne droplets	5-7 days	Not reported	631,571 Congenital rubella syndrome (CRS)	18	(1 CRS)	0	0
Tetanus	Penetrating injury, blood contamination,	3-10 days	18,781	200,000	25	5	6	0
Tuberculosis	Airborne	3 day - 15 weeks	8,000,000	1,600,000	15,056	784	6,572	373
Varicella	Airborne	2 weeks	Not reported	Not reported	22,841	32	Not reported	Not reported

Adopted from 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults. Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8).^[4]

JNC 7 Classification of Blood Pressure

According to the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure^[5] blood pressure values were classified as follows:

Blood Pressure Classification	Systolic (mm Hg)		Diastolic (mm Hg)
Normal	< 120	and	< 80
Pre-Hypertension	120-139	or	80-89
Stage 1 Hypertension	140-159	or	90-99
Stage 2 Hypertension	>160	or	>100

ESH/ESC Classification of Blood Pressure

In Europe, a different classification of blood pressure was introduced in 2007 by The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). According to the 2013 Guidelines for the Management of Arterial Hypertension, blood pressure values were classified as follows: ^[2]

Blood Pressure Classification	Systolic (mm Hg)		Diastolic (mm Hg)
Optimal	< 120	and	< 80
Normal	120-129	and/or	80-84
High Normal	130-139	and/or	85-89
Grade 1 Hypertension	140-159	and/or	90-99
Grade 2 Hypertension	160-179	and/or	100-109
Grade 3 Hypertension	≥ 180	and/or	≥110
Isolated Systolic Hypertension	≥140	and	<90

References

↑ Cuddy ML (2005). "Treatment of hypertension: guidelines from JNC 7 (the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 1)". J Pract Nurs. 55 (4): 17–21, quiz 22-3. PMID 16512265.
↑ ^2.0 ^2.1 Bonny A, Lacombe F, Yitemben M, Discazeaux B, Donetti J, Fahri P; et al. (2008). "The 2007 ESH/ESC guidelines for the management of arterial hypertension". J Hypertens. 26 (4): 825, author reply 825-6. doi:10.1097/HJH.0b013e3282f857e7. PMID 18327095.
↑ Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M; et al. (2013). "2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)". J Hypertens. 31 (7): 1281–357. doi:10.1097/01.hjh.0000431740.32696.cc. PMID 23817082.
↑ James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J; et al. (2014). "2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)". JAMA. 311 (5): 507–20. doi:10.1001/jama.2013.284427. PMID 24352797.
↑ Chobanian AV; et al. (2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report". JAMA. 289: 2560–72. PMID 12748199.

Template:WH Template:WS

[pmid16512265-1] Cuddy ML (2005). "Treatment of hypertension: guidelines from JNC 7 (the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure 1)". J Pract Nurs. 55 (4): 17–21, quiz 22-3. PMID 16512265.

[pmid18327095-2] 2.0 ^2.1 Bonny A, Lacombe F, Yitemben M, Discazeaux B, Donetti J, Fahri P; et al. (2008). "The 2007 ESH/ESC guidelines for the management of arterial hypertension". J Hypertens. 26 (4): 825, author reply 825-6. doi:10.1097/HJH.0b013e3282f857e7. PMID 18327095.

[pmid23817082-3] Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M; et al. (2013). "2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)". J Hypertens. 31 (7): 1281–357. doi:10.1097/01.hjh.0000431740.32696.cc. PMID 23817082.

[pmid24352797-4] James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J; et al. (2014). "2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)". JAMA. 311 (5): 507–20. doi:10.1001/jama.2013.284427. PMID 24352797.

[jnc7-5] Chobanian AV; et al. (2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report". JAMA. 289: 2560–72. PMID 12748199.

[1]

[2]

[3]

[4]

[5]

@@ Line 13: / Line 13: @@
 |
 {| style="border: 0px; font-size: 90%; margin: 3px;" align=center
-|+ align="center" style="background:#4479BA; color: #FFFFFF;" |'''Characteristics of diseases vaccinated against in most vaccine schedules<ref name= "WHO">[http://www.who.int/immunization/topics/en/ '''Estimated''' Incidence/deaths] World Health Organization ''Immunization, Vaccines and Biologicals'' Year 2000 data </ref><ref name= "CDC1">[http://www.cdc.gov/nip/publications/pink/Appendices/appdx-full-g.pdf '''Reported''' cases/deaths (pdf)] CDC "Pink Pages", Year 2002 data </ref><ref name=UK1>[http://www.immunisation.nhs.uk/article.php?id=91 '''Reported''' cases/deaths] NHS Immunisation Information, Year 2000 data (unless noted)</ref><ref>[http://www.who.int/mediacentre/factsheets/fs286/en/ See also: Estimated regional measles deaths (with uncertainty bounds)] Fact sheet N°286 (2004). The World Health Organization (WHO) and UNICEF. Revised March 2006.</ref><ref name= "WHO2005">(2005 data) Polio is endemic in only four countries; Nigeria, India, Afghanistan and Pakistan</ref><ref>(year 2000: due to [[neonatal tetanus]] from non-sterile delivery and/or umbilical severing tools)</ref><ref>[http://www.cdc.gov/nchstp/tb/surv/surv2005/PDF/table1.pdf ''Reported Tuberculosis in the United States'']  The National Center for HIV, STD, and TB Prevention Statistics: 2002</ref>'''
+|+ align="center" style="background:#4479BA; color: #FFFFFF;" |'''Comparison of Current Recommendations With JNC 7 Guidelines'''
 |-
 |rowspan="2" align="center" style="background:#DCDCDC;"| Disease